Phibro Animal Health
PAHC
#5087
Rank
HK$12.35 B
Marketcap
HK$304.84
Share price
-3.95%
Change (1 day)
73.19%
Change (1 year)

P/E ratio for Phibro Animal Health (PAHC)

P/E ratio as of December 2025 (TTM): 23.5

According to Phibro Animal Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.476. At the end of 2022 the company had a P/E ratio of 13.8.

P/E ratio history for Phibro Animal Health from 2014 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202213.8-1.5%
202114.0-10.74%
202015.7-31.08%
201922.851.52%
201815.0-16.4%
201718.012.04%
201616.0
201442.3

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Heska Corporation
HSKA
-62.2-364.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Archer Daniels Midland (ADM)
ADM
24.0 2.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Zoetis
ZTS
20.0-14.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
49.0 108.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
13.2-43.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Kindred Biosciences
KIN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.